{"id":8145,"date":"2017-10-17T11:26:48","date_gmt":"2017-10-17T13:26:48","guid":{"rendered":"http:\/\/www.revistahcsm.coc.fiocruz.br\/english\/?p=8145"},"modified":"2017-11-13T16:47:50","modified_gmt":"2017-11-13T18:47:50","slug":"the-thalidomide-tragedy","status":"publish","type":"post","link":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/the-thalidomide-tragedy\/","title":{"rendered":"The thalidomide tragedy"},"content":{"rendered":"<p style=\"text-align: right;\">17 October, 2017<\/p>\n<p style=\"text-align: left;\">The thalidomide tragedy in the late 1950s was a watershed moment for pharmaceutical regulation.<\/p>\n<p style=\"text-align: left;\">The paper\u00a0<a href=\"http:\/\/dx.doi.org\/10.1590\/s0104-59702017000300004\" target=\"_blank\" rel=\"noopener noreferrer\">The thalidomide tragedy: the struggle for victims&#8217; rights and improved pharmaceutical regulation<\/a>\u00a0(HCS-Manguinhos\u00a0vol.24\u00a0no.3 July\/Sept.\u00a02017) revisits the history of\u00a0 thalidomide and\u00a0its\u00a0consequences for\u00a0the\u00a0victims in Brazil.<\/p>\n<p style=\"text-align: left;\"><a href=\"http:\/\/dx.doi.org\/10.1590\/s0104-59702017000300004 \" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-8147\" src=\"http:\/\/www.revistahcsm.coc.fiocruz.br\/english\/wp-content\/uploads\/2017\/10\/talidomida.jpg\" alt=\"\" width=\"500\" height=\"333\" \/><\/a><\/p>\n<p style=\"text-align: left;\">Thalidomide was presented in the 1950s as a safe drug,\u00a0 but it was subsequently banned for its harmful effects, and in recent years has returned to treat patients with illnesses such as cancer and Hansen&#8217;s disease.<\/p>\n<p style=\"text-align: left;\">Written by\u00a0<span class=\"author-name\">Adriana\u00a0Moro and\u00a0<\/span><span class=\"author-name\">Noela\u00a0Invernizzi (Universidade Federal do Paran\u00e1), the paper shows the lack of strong standards for medication use, as well as how the tragedy was transformed into a public problem through the press. <\/span><\/p>\n<p style=\"text-align: left;\"><span class=\"author-name\">The article also shows that the increasing mobilization of victims was essential\u00a0to press for more effective regulation\u00a0of the industry<\/span>, leading to the application of the concepts of safety and pharmacovigilance for medications.<\/p>\n<p style=\"text-align: left;\">As the paper shows, the thalidomide case\u00a0\u00a0also triggered ethical debates about\u00a0 the practices of pharmaceutical industry and the\u00a0 rights of people with disabilities caused by the drug.<\/p>\n<p style=\"text-align: left;\">Related article in Manguinhos:<\/p>\n<p style=\"text-align: left;\">Moro, Adriana and Invernizzi, Noela. <a href=\"http:\/\/dx.doi.org\/10.1590\/s0104-59702017000300004\" target=\"_blank\" rel=\"noopener noreferrer\">The thalidomide tragedy: the struggle for victims&#8217; rights and improved pharmaceutical regulation<\/a>. Hist. cienc. saude-Manguinhos, Set 2017, vol.24, no.3, p.603-622. ISSN 0104-5970<\/p>\n<p style=\"text-align: left;\">Garc\u00eda, V\u00edctor Manuel. <a href=\"http:\/\/dx.doi.org\/10.1590\/S0104-59702007000400023\" target=\"_blank\" rel=\"noopener noreferrer\">Remedios secretos, drogas heroicas y medicinas de patente: una historia de la regulaci\u00f3n de los medicamentos en Antioquia, 1900-1940<\/a>. Hist. cienc. saude-Manguinhos, Dic 2007, vol.14, no.4, p.1437-1437. ISSN 0104-5970<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A review on the history of thalidomide and its consequences for the victims in Brazil.<\/p>\n","protected":false},"author":8,"featured_media":8146,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[4],"tags":[1040,1038,1037,1036,1039],"class_list":["post-8145","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-highlights","tag-media","tag-pharmaceutical-regulation","tag-risks","tag-thalidomide","tag-thalidomide-victims"],"_links":{"self":[{"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/posts\/8145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/comments?post=8145"}],"version-history":[{"count":4,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/posts\/8145\/revisions"}],"predecessor-version":[{"id":8151,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/posts\/8145\/revisions\/8151"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/media\/8146"}],"wp:attachment":[{"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/media?parent=8145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/categories?post=8145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/revistahcsm.coc.fiocruz.br\/english\/wp-json\/wp\/v2\/tags?post=8145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}